Aldeyra Therapeutics, Inc.

Bank of New York Mellon Corp ALDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

115,766

Value ($000)

600

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	600	0.0%	115,766	12/31/2025
2025 Q3	11/3/2025	636	0.0%	121,852	9/30/2025
2025 Q2	8/5/2025	426	0.0%	111,341	6/30/2025
2025 Q1	4/29/2025	638	0.0%	110,931	3/31/2025
2024 Q4	2/4/2025	583	0.0%	116,778	12/31/2024
2024 Q3	11/12/2024	636	0.0%	118,086	9/30/2024
2024 Q2	7/25/2024	648	0.0%	195,722	6/30/2024
2024 Q1	4/25/2024	526	0.0%	160,837	3/31/2024
2023 Q4	1/29/2024	597	0.0%	170,039	12/31/2023
2023 Q3	10/24/2023	1,185	0.0%	177,363	9/30/2023
2023 Q2	8/3/2023	1,490	0.0%	177,597	6/30/2023
2023 Q1	5/9/2023	658	0.0%	66,303	3/31/2023
2022 Q4	2/14/2023	460	0.0%	66,040	12/31/2022
2022 Q3	11/14/2022	354	0.0%	66,222	9/30/2022
2022 Q2	8/15/2022	314	0.0%	78,475	6/30/2022
2022 Q1	5/11/2022	932	0.0%	209,815	3/31/2022
2021 Q4	2/11/2022	749	0.0%	187,067	12/31/2021
2021 Q3	11/18/2021	1,614	0.0%	183,809	9/30/2021
2021 Q2	8/11/2021	2,516	0.0%	222,001	6/30/2021
2021 Q1	5/13/2021	563	0.0%	47,354	3/31/2021
2020 Q4	2/9/2021	388	0.0%	56,674	12/31/2020
2020 Q3	11/12/2020	115	0.0%	15,548	9/30/2020
2020 Q2	8/12/2020	65	0.0%	15,548	6/30/2020
2020 Q1	5/6/2020	165	0.0%	66,794	3/31/2020
2019 Q4	2/14/2020	431	0.0%	74,257	12/31/2019